SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-054623
Filing Date
2024-05-07
Accepted
2024-05-07 16:35:37
Documents
63
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vigl-20240331.htm   iXBRL 10-Q 1698510
2 EX-10.1 vigl-ex10_1.htm EX-10.1 21767
3 EX-31.1 vigl-ex31_1.htm EX-31.1 17422
4 EX-31.2 vigl-ex31_2.htm EX-31.2 17376
5 EX-32.1 vigl-ex32_1.htm EX-32.1 10415
6 EX-32.2 vigl-ex32_2.htm EX-32.2 10385
  Complete submission text file 0000950170-24-054623.txt   6655124

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vigl-20240331.xsd EX-101.SCH 1198005
66 EXTRACTED XBRL INSTANCE DOCUMENT vigl-20240331_htm.xml XML 882951
Mailing Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472
Business Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472 857-254-4445
Vigil Neuroscience, Inc. (Filer) CIK: 0001827087 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41200 | Film No.: 24922611
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)